Search results
Novo to acquire heart failure drug in $1B deal for Cardior
BioPharma Dive via Yahoo Finance· 3 months agoDive Brief: Novo Nordisk will pay as much as $1 billion to acquire RNA drug developer Cardior and...
One month after experimental pig heart transplant, doctors say they see no signs of rejection or...
CNN via Yahoo News· 8 months agoOne month after an experimental procedure to transplant the heart of a genetically modified pig into...
Second person to receive experimental pig heart transplant dies nearly six weeks after procedure
CNN via Yahoo News· 7 months agoLawrence Faucette, the second living person to receive a genetically modified pig heart in a...
Failure may not be such a great teacher after all, new research suggests
NBC Universal via AOL· 2 days agoThe myth that failure is always a good teacher may need an update. People tend to overestimate the...
Pig heart transplant recipient died of heart failure
The Independent via Yahoo News· 2 years agoThe death of the man who received a groundbreaking pig heart transplant this year occurred from heart failure, concluded doctors at the University of...
New drug may help people with uncontrolled high blood pressure
NBC Universal via AOL· 2 years agoAn experimental drug could eventually offer hope to millions of people struggling with uncontrolled...
FDA staff reviewers flag safety concerns over Cytokinetics' heart drug
Reuters via Yahoo News· 2 years agoThe late-stage data raises concerns about the drug's dose-limiting risks of heart failure, the...
Experimental drugs aim to surpass weight-loss stars like Ozempic and Wegovy
CNN via Yahoo News· 1 year agoThe new crop of drugs on the market for type 2 diabetes and obesity, including popular medications...
Heart failure death rates on the rise, but local specialists say there's more to that
The Spokesman-Review, Spokane, Wash. via Yahoo News· 1 week agoJun. 3—Heart failure deaths are climbing after decades of a decline, starting with a reversal from 2012 to 2021, according to research in the Journal of the American Medical Association. The ...
Cytokinetics CEO: Why It's OK Not Being An Overnight Success
Investor's Business Daily· 2 years agoNobody will accuse Cytokinetics of being an "overnight success," Chief Executive Robert Blum says....